Pain management for hepatobiliary cancer.

Current Treatment Options in Oncology
Daniel E Halpert, Michael A Erdek

Abstract

Although many options exist to address hepatobiliary cancer-induced pain, it remains undertreated and has an adverse impact on quality of life. Fortunately, if addressed appropriately, the majority of patients can be treated successfully. This pain may be nociceptive, neuropathic, or a combination of the two. A multimodality approach including oral and intravenous opioid and non-opioid medications, and interventional approaches including celiac plexus blocks and implantation of drug delivery systems for intrathecal delivery of opioids can be considered and utilized as appropriate. We review the pathophysiology of pain, the approach to correctly diagnosing the different types of pain, the appropriate treatment recommendations, and how to avoid and address the common side effects resulting from these treatments.

References

Apr 1, 1982·Journal of Computer Assisted Tomography·J N BuyR C Singler
Mar 3, 1994·The New England Journal of Medicine·C S CleelandK J Pandya
Mar 1, 1993·AJR. American Journal of Roentgenology·D F RomanelliF W Heiss
May 21, 1999·Lancet·R K Portenoy, P Lesage
Jul 27, 1999·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G H SakorafasM G Sarr
Dec 20, 1999·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·E K Abdalla, S R Schell
Apr 28, 2000·Cancer Control : Journal of the Moffitt Cancer Center·R Miguel
Aug 22, 2000·Cancer·P L ManfrediR Payne
Mar 10, 2001·British Journal of Cancer·G W HanksUNKNOWN Expert Working Group of the Research Network of the European Association for Palliative Care
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithUNKNOWN Implantable Drug Delivery Systems Study Group
Dec 5, 2003·Journal of Pain and Symptom Management·Sebastiano MercadanteAlessandra Casuccio
Mar 25, 2004·AJR. American Journal of Roentgenology·Okan AkhanMusturay Karcaaltincaba
Jul 22, 2004·The Cochrane Database of Systematic Reviews·C Quigley
Oct 21, 2004·Pain·Michael J CousinsDaniel B Carr
Apr 9, 2005·Cancer Investigation·Leonidas C GoudasDaniel B Carr
Jun 14, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Julia RileyKen Welsh
Feb 18, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carla RipamontiFranco De Conno
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Nov 15, 2006·The American Journal of Gastroenterology·Brian M Yan, Robert P Myers
Feb 20, 2007·Alimentary Pharmacology & Therapeutics·J F Johanson, J Kralstein
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gabrielle R Goldberg, R Sean Morrison
Aug 7, 2007·Digestive Diseases and Sciences·Chun-Lei ZhangJia-Xiang Ni
Aug 22, 2007·The Clinical Journal of Pain·Xavier Garcia-ErolesJosep Porta
Oct 16, 2007·Pediatric Clinics of North America·Stefan J Friedrichsdorf, Tammy I Kang
Dec 14, 2007·The Clinical Journal of Pain·Sebastiano MercadanteSalvatore Mangione
Feb 27, 2008·The Medical Clinics of North America·Steven Z Pantilat, Margaret Isaac
Mar 21, 2008·European Journal of Pain : EJP·Sebastiano MercadanteSalvatore Mangione
Mar 25, 2008·Therapeutics and Clinical Risk Management·Mario MandalàSandro Barni

❮ Previous
Next ❯

Citations

Dec 18, 2013·Current Problems in Cancer·Michael A ErdekSusannah G Ellsworth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.